Morgan Stanley
Morgan Stanley (MS-PL) Financial Performance & Income Statement Overview
Explore the financials of Morgan Stanley (MS-PL), including yearly and quarterly data on income, cash flow, and balance sheets.
Morgan Stanley (MS-PL) Income Statement & Financial Overview
Explore comprehensive income reports for Morgan Stanley MS-PL, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $27.91B | $25.98B | $26.33B | $25.49B |
| Cost of Revenue | $11.53B | $11.05B | $12.07B | $11.54B |
| Gross Profit | $16.38B | $14.93B | $14.26B | $13.95B |
| Gross Profit Ratio | $0.59 | $0.57 | $0.54 | $0.55 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.62B | $6.57B | $6.96B | $6.71B |
| Operating Expenses | $10.84B | $10.02B | $10.04B | $9.87B |
| Total Costs & Expenses | $22.37B | $21.08B | $22.11B | $21.41B |
| Interest Income | $13.75B | $13.49B | $14.19B | $13.53B |
| Interest Expense | $11.39B | $10.94B | $11.99B | $11.46B |
| Depreciation & Amortization | $865.00M | $1.65B | $1.27B | $1.27B |
| EBITDA | $6.41B | $6.55B | $5.49B | $5.34B |
| EBITDA Ratio | $0.23 | $0.25 | $0.21 | $0.21 |
| Operating Income | $5.54B | $4.91B | $4.22B | $4.07B |
| Operating Income Ratio | $0.20 | $0.19 | $0.16 | $0.16 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $5.54B | $4.91B | $4.22B | $4.07B |
| Income Before Tax Ratio | $0.20 | $0.19 | $0.16 | $0.16 |
| Income Tax Expense | $1.17B | $1.18B | $995.00M | $957.00M |
| Net Income | $4.32B | $3.71B | $3.19B | $3.08B |
| Net Income Ratio | $0.15 | $0.14 | $0.12 | $0.12 |
| EPS | $2.62 | $2.25 | $1.91 | $1.85 |
| Diluted EPS | $2.60 | $2.22 | $1.88 | $1.82 |
| Weighted Avg Shares Outstanding | $1.58B | $1.58B | $1.59B | $1.59B |
| Weighted Avg Shares Outstanding (Diluted) | $1.60B | $1.61B | $1.61B | $1.61B |
The company's financials show resilient growth, with revenue advancing from $25.49B in Q2 2024 to $27.91B in Q1 2025. Gross profit remained healthy with margins at 59% in Q1 2025 compared to 55% in Q2 2024. Operating income hit $5.54B last quarter, sustaining a consistent 20% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $6.41B. Net income rose to $4.32B, while earnings per share reached $2.62. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan